Sitravatinib potentiates immune checkpoint blockade in refractory cancer models
Wenting Du(The University of Texas Southwestern Medical Center), Rolf A. Brekken(Southwestern Medical Center)
Cited by 111
Related Papers
Cellular heterogeneity during mouse pancreatic ductal adenocarcinoma progression at single-cell resolution
|JCI Insight|2019|281
Phosphorylation of Akt and ERK1/2 Is Required for VEGF-A/VEGFR2-Induced Proliferation and Migration of Lymphatic Endothelium
|PLoS ONE|2011|99
Targeting TGFβR2‐mutant tumors exposes vulnerabilities to stromal TGFβ blockade in pancreatic cancer
|EMBO Molecular Medicine|2019|87
Losartan Slows Pancreatic Tumor Progression and Extends Survival of SPARC-Null Mice by Abrogating Aberrant TGFβ Activation
|PLoS ONE|2012|77
Cellular heterogeneity during mouse pancreatic ductal adenocarcinoma progression at single-cell resolution
|bioRxiv (Cold Spring Harbor Laboratory)|2019|75